vimarsana.com

Latest Breaking News On - Worth venture partners - Page 6 : vimarsana.com

CalAmp (NASDAQ:CAMP) Receives New Coverage from Analysts at StockNews com

StockNews.com initiated coverage on shares of CalAmp (NASDAQ:CAMP – Free Report) in a report released on Friday morning. The firm issued a sell rating on the Wireless communications provider’s stock. CalAmp Trading Up 3.1 % Shares of CAMP stock opened at $3.37 on Friday. The company has a 50 day moving average of $3.33 and […]

AIGH Capital Management LLC Takes $4 92 Million Position in Delcath Systems, Inc (NASDAQ:DCTH)

AIGH Capital Management LLC bought a new position in shares of Delcath Systems, Inc. (NASDAQ:DCTH – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 1,182,198 shares of the company’s stock, valued at approximately $4,918,000. Delcath Systems accounts for 2.0% of AIGH Capital […]

AIGH Capital Management LLC Sells 2,625,753 Shares of TFF Pharmaceuticals, Inc (NASDAQ:TFFP)

AIGH Capital Management LLC lessened its stake in shares of TFF Pharmaceuticals, Inc. (NASDAQ:TFFP – Free Report) by 98.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 29,482 shares of the company’s stock after selling 2,625,753 shares during the period. AIGH Capital Management LLC’s holdings in TFF Pharmaceuticals were worth $207,000 as of […]

AIGH Capital Management LLC Has $6 73 Million Holdings in BrainsWay Ltd (NASDAQ:BWAY)

AIGH Capital Management LLC cut its position in BrainsWay Ltd. (NASDAQ:BWAY – Free Report) by 23.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,038,528 shares of the company’s stock after selling 316,494 shares during the quarter. BrainsWay comprises approximately 2.7% […]

AIGH Capital Management LLC Has $9 62 Million Stock Position in Alimera Sciences, Inc (NASDAQ:ALIM)

AIGH Capital Management LLC lowered its stake in shares of Alimera Sciences, Inc. (NASDAQ:ALIM – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,226,068 shares of the biopharmaceutical company’s stock after selling 146,504 […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.